ISIN
FR0010844464
Ticker
ALMDP
Sector
Sub-Industry
Country
France
Year Founded
2003
Medesis Pharma is a clinical-stage Pharmaceutical Biotechnology company developing innovative technology (AONYS®) for the delivery of therapeutic molecules to treat diseases with no current efficacious treatment.
Legal structure :
Montpellier (France) Headquarters
Montreal (Canada) 100% subsidiary. Medesis Pharma Inc. is a subsidiary for collaborations with McGill University and the University of Montreal.
Worldwide
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
16.05.2024 | None | Other | Sell | EUR 1,170.00 |
18.01.2024 | None | Other | Sell | EUR 669.60 |
21.07.2023 | None | Other | Sell | EUR 1,400.00 |
04.07.2023 | None | Other | Sell | EUR 7,100.00 |
23.05.2023 | None | Other | Sell | EUR 6,908.00 |
FR0010844464
969500C15M96P00UR648
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.